انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
🔒 BONUS Paid Subscribers: High Light Reel from The Senate Hearing about Ozempic and Wegovy Pricing
Manage episode 443427424 series 3465852
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Health Education Labor & Pensions Committee Website
https://www.help.senate.gov/
Direct Link to Senate Hearing
https://www.help.senate.gov/hearings/why-is-novo-nordisk-charging-americans-with-diabetes-and-obesity-outrageously-high-prices-for-ozempic-and-wegovy
___________________________________________________________________
On September 24, 2024, the U.S. Senate's Health, Education, Labor & Pensions Committee held a crucial hearing titled "Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?" This hearing gained even greater significance with the recent news of the Tirzepatide injection being removed from the FDA's shortage list, emphasizing the ongoing challenges in medication accessibility.
In a tense atmosphere, Novo Nordisk CEO Lars Jorgensen faced rigorous questioning about the soaring prices of these essential diabetes and obesity medications. Lawmakers and healthcare advocates pressed for transparency, shedding light on broader issues of healthcare affordability that affect millions of Americans.
With the stakes exceptionally high, the revelations from this hearing are poised to ignite further discussions in the ongoing battle for equitable healthcare access nationwide. The event not only highlighted the urgent need for reform but also called into question the ethics of pharmaceutical pricing in the United States, underlining the critical importance of making life-saving medications affordable for all.
This is the Highlight reel from the 2 hour hearing showing what The PlusSidez believes to be crucial take away,
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
_____________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
129 حلقات
Manage episode 443427424 series 3465852
Resources for the Community:
___________________________________________________________________
https://linktr.ee/theplussidezpodcast
Ro - Telehealth for GLP1 weight management
https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55
Health Education Labor & Pensions Committee Website
https://www.help.senate.gov/
Direct Link to Senate Hearing
https://www.help.senate.gov/hearings/why-is-novo-nordisk-charging-americans-with-diabetes-and-obesity-outrageously-high-prices-for-ozempic-and-wegovy
___________________________________________________________________
On September 24, 2024, the U.S. Senate's Health, Education, Labor & Pensions Committee held a crucial hearing titled "Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?" This hearing gained even greater significance with the recent news of the Tirzepatide injection being removed from the FDA's shortage list, emphasizing the ongoing challenges in medication accessibility.
In a tense atmosphere, Novo Nordisk CEO Lars Jorgensen faced rigorous questioning about the soaring prices of these essential diabetes and obesity medications. Lawmakers and healthcare advocates pressed for transparency, shedding light on broader issues of healthcare affordability that affect millions of Americans.
With the stakes exceptionally high, the revelations from this hearing are poised to ignite further discussions in the ongoing battle for equitable healthcare access nationwide. The event not only highlighted the urgent need for reform but also called into question the ethics of pharmaceutical pricing in the United States, underlining the critical importance of making life-saving medications affordable for all.
This is the Highlight reel from the 2 hour hearing showing what The PlusSidez believes to be crucial take away,
______________________________________________________________________
⭐️Mounjaro Stanley⭐️
griffintumblerco.Etsy.com
Use code PODCAST10 for $ OFF
______________________________________________________________________
Join this channel to get access to perks:
_____________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy
Kim Carlos, Executive Producer
TikTok
https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc
https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr
Kat Carter, Associate Producer
TikTok
https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc
https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==
129 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.